Vulnerability Monitor

The vendors, products, and vulnerabilities you care about

immunix

About This Vendor

immunix is a technology vendor producing software and infrastructure products. As a software provider, immunix's broad product portfolio across multiple domains—including operating systems, cloud infrastructure, enterprise applications, databases, networking, and security tools—creates a large attack surface. Additionally, long support cycles, widespread deployment, and continuous feature development contribute to the accumulation of discovered vulnerabilities over time. Major vendors typically report higher CVE counts not necessarily due to inferior security, but because of greater exposure to security research, responsible disclosure practices, and the sheer complexity of maintaining multiple product lines and legacy systems. Regular security assessments and patching of immunix's products are critical for organizations running their software in production environments.

Vulnerability Trends for This Vendor

SecUtils has indexed 27 known vulnerabilities from immunix. This includes 1 critical-severity issue and 10 high-severity issues that represent significant risk. These vulnerabilities affect 33 distinct products across immunix's portfolio, demonstrating the breadth of the vendor's product ecosystem and the importance of comprehensive patch management strategies. Disclosure dates span from 1999 through 2003, with recent active disclosure activity. Organizations deploying immunix products should maintain active vulnerability monitoring, prioritize critical patches, and implement compensating controls where patches cannot be applied immediately.

ID Date Published Last Modified Severity (CVSSv3) Severity (CVSSv2) Exploit Available
CVE-1999-1111 1999-11-09 2025-04-03 - 7.5 Likely
CVE-2000-1213 2000-10-18 2025-04-03 - 7.5 Likely
CVE-2000-1214 2000-10-18 2025-04-03 - 4.6 Unknown
CVE-2000-0844 2000-11-14 2025-04-03 - 10.0 Likely
CVE-2000-0963 2000-12-19 2025-04-03 - 7.2 Unknown
CVE-2000-1095 2001-01-09 2025-04-03 - 7.2 Unknown
CVE-2000-1134 2001-01-09 2025-04-03 - 7.2 Unknown
CVE-2001-0116 2001-03-12 2025-04-03 - 1.2 Unknown
CVE-2001-0117 2001-03-12 2025-04-03 - 1.2 Unknown
CVE-2001-0118 2001-03-12 2025-04-03 - 1.2 Unknown
CVE-2001-0119 2001-03-12 2025-04-03 - 1.2 Unknown
CVE-2001-0120 2001-03-12 2025-04-03 - 1.2 Unknown
CVE-2001-0138 2001-03-12 2025-04-03 - 1.2 Unknown
CVE-2001-0139 2001-03-12 2025-04-03 - 1.2 Unknown
CVE-2001-0140 2001-03-12 2025-04-03 - 1.2 Unknown
CVE-2001-0142 2001-03-12 2025-04-03 - 1.2 Unknown
CVE-2001-0143 2001-03-12 2025-04-03 - 1.2 Unknown
CVE-2001-0170 2001-03-26 2025-04-03 - 2.1 Unknown
CVE-2001-0416 2001-06-27 2025-04-03 - 2.1 Unknown
CVE-2001-0473 2001-06-27 2025-04-03 - 7.5 Likely
CVE-2001-1030 2001-07-18 2025-04-03 - 7.5 Likely
CVE-2001-0641 2001-09-20 2025-04-03 - 4.6 Unknown
CVE-2001-0736 2001-10-18 2025-04-03 - 2.1 Unknown
CVE-2001-0738 2001-10-18 2025-04-03 - 5.0 Likely
CVE-2002-0083 2002-03-15 2025-04-03 9.8 10.0 Likely
CVE-2000-1208 2002-08-12 2025-04-03 - 7.2 Unknown
CVE-2002-1565 2003-06-16 2025-04-03 - 7.5 Likely

How SecUtils Normalizes Vendor Data

SecUtils aggregates National Vulnerability Database (NVD) and MITRE records for immunix by normalizing vendor identifiers across diverse data sources, mapping vendor names to their associated product lines, and collecting all known vulnerabilities under a unified vendor context. For every CVE associated with immunix's products, we extract and structure Common Platform Enumeration (CPE) data, Common Weakness Enumeration (CWE) categories, CVSS severity metrics, and reference links to enable rapid vulnerability identification and asset correlation. This record contains no exploit code, proof-of-concept instructions, or attack methodologies—only defensive intelligence necessary for patch management, risk assessment, and vendor vulnerability tracking.